A randomized double-blind study of atomoxetine versus placebo for attention-deficit/hyperactivity disorder symptoms in children with autism spectrum disorder.
J Am Acad Child Adolesc Psychiatry. 2012 Jul; 51(7):733-41
Robert Findling1 and Molly McVoy2
16 Jul 2012
|
Clinical Trial
The treatment of co-morbid symptoms in children with autism is often challenging, especially because youths in the pervasive developmental disorder (PDD) spectrum appear to be at higher risk for developing side effects when prescribed psychotropic medications. Understanding how to meet the specific needs of this population is im and...
INDIVIDUAL SUBSCRIPTIONS
Get instant access to Article Recommendations from more than 5,000 expert scientists and clinical researchers, assisted by 5,000 associates, by taking out a monthly subscription. The first month of your subscription will be free of charge.
Start your personal subscription today.
Subscribe for $9.95/monthINSTITUTIONAL SUBSCRIPTIONS
Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.
Recommend to your LibrarianIf you are a librarian or information manager, you may request an extended free trial for your academic or corporate institution.
Request an Institutional Trialyour institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.
If you think you should be able to access this content, please contact us.